PL334241A1 - Leucotriene antagones against squamous epithelium carcinoma of oral cavity - Google Patents

Leucotriene antagones against squamous epithelium carcinoma of oral cavity

Info

Publication number
PL334241A1
PL334241A1 PL97334241A PL33424197A PL334241A1 PL 334241 A1 PL334241 A1 PL 334241A1 PL 97334241 A PL97334241 A PL 97334241A PL 33424197 A PL33424197 A PL 33424197A PL 334241 A1 PL334241 A1 PL 334241A1
Authority
PL
Poland
Prior art keywords
antagones
leucotriene
oral cavity
squamous epithelium
epithelium carcinoma
Prior art date
Application number
PL97334241A
Other languages
English (en)
Inventor
Jerome H Fleisch
William T Jackson
Jason S Sawyer
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of PL334241A1 publication Critical patent/PL334241A1/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/194Carboxylic acids, e.g. valproic acid having two or more carboxyl groups, e.g. succinic, maleic or phthalic acid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/192Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A61K31/343Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide condensed with a carbocyclic ring, e.g. coumaran, bufuralol, befunolol, clobenfurol, amiodarone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Neurosurgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Neurology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Pyrane Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
PL97334241A 1996-12-13 1997-12-02 Leucotriene antagones against squamous epithelium carcinoma of oral cavity PL334241A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US3426996P 1996-12-13 1996-12-13
US4087497P 1997-03-21 1997-03-21
PCT/US1997/021953 WO1998025615A1 (en) 1996-12-13 1997-12-02 Leukotriene antagonists for oral squamous cell carcinoma

Publications (1)

Publication Number Publication Date
PL334241A1 true PL334241A1 (en) 2000-02-14

Family

ID=26710754

Family Applications (1)

Application Number Title Priority Date Filing Date
PL97334241A PL334241A1 (en) 1996-12-13 1997-12-02 Leucotriene antagones against squamous epithelium carcinoma of oral cavity

Country Status (14)

Country Link
EP (1) EP0964683A4 (de)
JP (1) JP2001509142A (de)
KR (1) KR20000069452A (de)
CN (1) CN1245429A (de)
AU (1) AU726215B2 (de)
CA (1) CA2274855A1 (de)
EA (1) EA002742B1 (de)
IL (1) IL130304A0 (de)
NO (1) NO992846L (de)
NZ (1) NZ335922A (de)
PL (1) PL334241A1 (de)
TR (1) TR199901307T2 (de)
UA (1) UA47505C2 (de)
WO (1) WO1998025615A1 (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2004505047A (ja) 2000-07-28 2004-02-19 キャンサー・リサーチ・テクノロジー・リミテッド 複合治療による癌治療
GB0121285D0 (en) 2001-09-03 2001-10-24 Cancer Res Ventures Ltd Anti-cancer combinations
GB2386836B (en) 2002-03-22 2006-07-26 Cancer Res Ventures Ltd Anti-cancer combinations
GB2394658A (en) 2002-11-01 2004-05-05 Cancer Rec Tech Ltd Oral anti-cancer composition
US8093253B2 (en) * 2008-03-06 2012-01-10 Hoffmann-La Roche Inc. Leukotriene B4 inhibitors
KR101898879B1 (ko) 2014-03-05 2018-09-14 재단법인 진안홍삼연구소 홍삼 가공 추출물을 유효성분으로 함유하는 구강편평세포암의 예방, 개선 또는 치료를 위한 조성물

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6372648A (ja) * 1986-09-16 1988-04-02 Sumitomo Pharmaceut Co Ltd 新規不飽和脂肪酸誘導体
ZA929051B (en) * 1991-11-25 1994-05-23 Lilly Co Eli Substituted phenyl phenol leukotriene antagonists
PH30449A (en) * 1991-11-25 1997-05-28 Lilly Co Eli Substituted phenyl phenol leukotriene antagonists

Also Published As

Publication number Publication date
AU726215B2 (en) 2000-11-02
CN1245429A (zh) 2000-02-23
AU7845198A (en) 1998-07-03
UA47505C2 (uk) 2002-07-15
JP2001509142A (ja) 2001-07-10
NZ335922A (en) 2000-12-22
EP0964683A4 (de) 2002-08-14
EA002742B1 (ru) 2002-08-29
IL130304A0 (en) 2000-06-01
TR199901307T2 (xx) 1999-08-23
EA199900543A1 (ru) 2000-02-28
KR20000069452A (ko) 2000-11-25
CA2274855A1 (en) 1998-06-18
NO992846D0 (no) 1999-06-11
WO1998025615A1 (en) 1998-06-18
EP0964683A1 (de) 1999-12-22
NO992846L (no) 1999-06-11

Similar Documents

Publication Publication Date Title
AU4721897A (en) Tetrahydroisoquinoline derivatives
AUPM329894A0 (en) Face protector shade
ZA977103B (en) Benzopiperidine derivatives
GB2302048B (en) Rotating nozzle
PL334241A1 (en) Leucotriene antagones against squamous epithelium carcinoma of oral cavity
GB2319461B (en) Safety spoon
AP9600897A0 (en) anti-HIV triple combination
HU9603627D0 (en) Anti-hiv triple combination
GB2318813B (en) Cavity closer
AU1230597A (en) Denture cleaning
AU1233597A (en) Tetrahydroisoquinoline derivatives
GB9418028D0 (en) Cavity arrangements
AU5175898A (en) End face mounted insert
AU1232497A (en) Denture cleansing
GB2293043B (en) Cavity arrangements
GR3034355T3 (en) End protector
GB2314101B (en) Cavity closer
HUP9902048A3 (en) Compositions and methods for improving the performance of long-wearing cosmetic products
AU7716896A (en) Earmuff
CA74967S (en) Plaque
CA74883S (en) Plaque
AUPO958597A0 (en) Face protector
GB9615005D0 (en) Smooth sparkler
TW352730U (en) Protector of yarn-delivering roller
GB2310826B (en) Improvements relating to the prevention of fraud